• Micropos Medical posted Q2 net sales of SEK 1.11 million, down 66.92% year over year.
• Loss after financial items widened to SEK 9.51 million; EPS was SEK -0.05.
• First-half net sales fell 73.36% to SEK 1.59 million; loss after financial items widened to SEK 16.46 million.
• Equity stood at SEK 21.81 million at end-June, with an 80% equity ratio; cash and bank totaled SEK 17.34 million.
• Completed a share issue that raised SEK 24.5 million net; had about 15 active customers, with about 430 patients treated using Raypilot.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Micropos Medical AB published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.